Fig. 1: Neutralizing activity of NiV mAbs. | npj Vaccines

Fig. 1: Neutralizing activity of NiV mAbs.

From: Antigenic landscape of Nipah virus attachment glycoprotein analysis reveals a protective immunodominant epitope across species

Fig. 1

A Neutralization curve plots of NiV mAbs against VSV-based NiVB pseudovirus. B Neutralizing activity of NiV mAbs at 10 μg/mL against VSV-based HeV pseudovirus. C Neutralization curve plots of NiV mAbs against VSV-based HeV pseudovirus. D–F Neutralization activity of NiV mAbs against authentic NiVM (D), HeV (E), or NiVB viruses (F). Three previously reported NiV mAbs (HENV-26, nAH1.3 and HENV-32) were included as controls and indicated by hollow circle. Representative results from three independent experiments performed in duplicate are shown in (A) and (C). Data represented as mean ± SEM from two or three independent experiments performed in triplicate (B) or quadruplicate (D–F).

Back to article page